UNSPSC 85812109: Introduction of anti-inflammatory into eye, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into eye, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0C33Z

UNSPSC 85812109 Introduction of anti-inflammatory into eye, percutaneous approach is a Commodity code. State and local governments show minimal recent procurement activity under this specific medical procedure code, with recent opportunities tagged to it bearing little connection to ophthalmic anti-inflammatory delivery. The recent solicitations attributed to this code—ranging from virtual urgent care services and PACE program operations to occupational health screenings, employee wellness platforms, and opioid use disorder treatment—fall outside the narrow scope of percutaneous intraocular anti-inflammatory injection procedures.

The mismatch between the code's clinical specificity and the breadth of opportunities assigned to it suggests either systematic miscoding in state and local procurement systems or that the code does not meaningfully represent current purchasing patterns. Among the opportunities in the dataset, only one—San Mateo County's handheld retinal screening devices and services solicitation (RFP 660002627264, due November 6, 2026)—touches on eye-care delivery, and it focuses on portable diagnostic imaging and EPIC integration rather than therapeutic anti-inflammatory administration. No state or local body appears to be actively soliciting ophthalmologic pharmaceutical procedures under this code in the current market window. Buyers pursuing ophthalmic therapeutics should verify actual UNSPSC coding with customer procurement offices before pursuing opportunities tagged to this Commodity, as the tagging appears unreliable.